OligoTune

1 known investors

Oligotune is developing RNA-based cancer immunotherapy treatments that target solid tumours with enhanced precision. The company uses a data-driven pre-clinical R&D pipeline to address mechanisms in cancer immunotherapy that existing treatments do not adequately target.